You can use your existing Medical Independent, MediLearning or PharmacistCPD account to log in.


Medicalindependent.ie is Ireland's only investigative medical news website for doctors, healthcare professionals and anyone with an interest in health issues.

Established in 2010, along with its sister publication The Medical Independent, our stated aim is to investigate and analyse the major issues affecting healthcare and the medical profession in Ireland. The Medical Independent has won a number of awards for its investigative journalism, and its stories are frequently picked up by national digital, broadcast and print media. The Medical Independent is published by GreenCross Publishing.

Address: Top Floor, 111 Rathmines Road Lr, Dublin 6

Tel: 353 (01) 441 0024

GreenCross Publishing is owned by Graham Cooke.


The benefits of registering: only registered users:
  • receive the ecCopy two days prior to the printed edition.
  • have automatic access to our free CPD sites.
  • can partake in our online MCQs.
  • can enter our online sports quiz.

Sign up now for ease of access to The Medical Independent, Ireland’s most frequently published medical newspaper, delivering award-winning news and investigative reporting.

Download the new Mindo app for both IOS & Android.

  • Get notified when a story goes live
  • Access Premium Content
  • Read Offline
 
[the_ad_placement id="main-ldb-public"]
[the_ad_placement id="main-ldb-mobile-public"]

You are reading 1 of 2 free-access articles allowed for 30 days

Multi-modal analgesic treatment for cancer pain reduces the potential harm of long-term opioid use

By Dermot - 22nd Oct 2019 | 7 views

Multi-modal pain treatment for cancer patients, as well as continuous assessment and understanding the risk factors for opioid misuse, will reduce the potential harm of opioids in cancer care, delegates at the European Pain Federation’s biennial Congress in Valencia, Spain, were told by a leading US expert.

Prof Judith Paice, Director of the Cancer Pain Programme at the Feinberg School of Medicine at Northwestern University in Chicago, US, told the 3,500 delegates at the EFIC Congress that comprehensive assessment and reassessment of pain, function and risk factors for misuse must all be incorporated into oncology and pain care for patients with a malignant cancer.

Prof Paice said: “The increase in cancer prevalence is the result of extraordinary advances in diagnosis and treatment. Some of these cancers and their treatments can produce acute and persistent pain. However, the long-term use of opioids to treat that pain may produce harm.”

Prof Paice continued: “Pain is a serious complication of cancer and cancer treatment and it can affect all aspects of an individual’s life.

“But there are other ways we can relieve pain apart from opioids, such as non-opioids, adjuvant analgesics, as well as a great many non-drug therapies.

“Cancer patients should receive a multi-modal pain treatment strategy, that is constantly being assessed against how they are doing. That way, we can use lower doses of opioids while still providing excellent pain control.

“Education is key, both for healthcare professionals that treat cancer patients, as well as for patients and their family members, in particular to overcome some of the stigma that may be attached to non-pharmacological treatments for pain.”

Leave a Reply

[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]
Latest Issue
The Medical Independent – 24 June 2021

You need to be logged in to access this content. Please login or sign up using the links below.

[the_ad_placement id="main-mpu-public"]
Most Read
[the_ad_placement id="main-ldb-public-2"]
[the_ad_placement id="main-ldb-mobile-public-2"]